These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 11357356)

  • 1. [Decrease in RNA-dependent DNA polymerase activity of recombinant human immunodeficiency virus reverse transcriptase in bidistilled modified water].
    Shvetsov IuP; Novikov VV; Fesenko EE; Aliushev FK; Eremin SM; Markov IA; Ten IuA
    Biofizika; 2001; 46(2):379-80. PubMed ID: 11357356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
    Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
    Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the RNA dependent DNA polymerase of bovine leukemia virus.
    Demirhan I; Altanerova V; Chandra A; Gerber T; Hofmann D; Altaner C; Chandra P
    Anticancer Res; 1996; 16(5A):2501-5. PubMed ID: 8917342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
    Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus agalactiae DNA polymerase I is an efficient reverse transcriptase.
    Bahrami F; Jestin JL
    Biochimie; 2008; 90(11-12):1796-9. PubMed ID: 18706966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus.
    Das D; Georgiadis MM
    Structure; 2004 May; 12(5):819-29. PubMed ID: 15130474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catalytic properties of the recombinant reverse transcriptase of bovine immunodeficiency virus.
    Avidan O; Bochner R; Hizi A
    Virology; 2006 Jul; 351(1):42-57. PubMed ID: 16631225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Substrate properties of dinucleoside 5',5"-oligophosphates in the reactions catalyzed by HIV reverse transcriptase, E. coli DNA polymerase I, and E. coli RNA polymerase].
    Bioorg Khim; 2005; 31(1):54-64. PubMed ID: 15787214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photoaffinity modification of human immunodeficiency virus reverse transcriptase with an analog of deoxyuridine-5'-triphosphate, containing an arylazide group].
    Shcherbik NV; Khodyreva SN; Vlasov VA; Dobrikov MI; Dymshits GM; Lavrik OI
    Mol Biol (Mosk); 1997; 31(2):344-52. PubMed ID: 9213764
    [No Abstract]   [Full Text] [Related]  

  • 11. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
    Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J
    J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
    García-Lerma JG; Nidtha S; Heneine W
    J Infect Dis; 2001 Aug; 184(4):507-10. PubMed ID: 11471110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptase.
    Tachedjian G; Radzio J; Sluis-Cremer N
    Proteins; 2005 Jul; 60(1):5-13. PubMed ID: 15852304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
    Bakhanashvili M
    Oncogene; 2001 Nov; 20(52):7635-44. PubMed ID: 11753641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.
    Cancio R; Spadari S; Maga G
    Biochem J; 2004 Nov; 383(Pt. 3):475-82. PubMed ID: 15315477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
    Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
    Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs).
    Hang JQ; Li Y; Yang Y; Cammack N; Mirzadegan T; Klumpp K
    Biochem Biophys Res Commun; 2007 Jan; 352(2):341-50. PubMed ID: 17113568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
    Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
    Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: quantum chemical calculations based on the ONIOM method.
    Saen-oon S; Kuno M; Hannongbua S
    Proteins; 2005 Dec; 61(4):859-69. PubMed ID: 16245320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer.
    Peletskaya EN; Boyer PL; Kogon AA; Clark P; Kroth H; Sayer JM; Jerina DM; Hughes SH
    J Virol; 2001 Oct; 75(19):9435-45. PubMed ID: 11533206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.